PUBLISHER: TechNavio | PRODUCT CODE: 1792216
PUBLISHER: TechNavio | PRODUCT CODE: 1792216
The AI in precision medicine market is forecasted to grow by USD 880.7 mn during 2024-2029, accelerating at a CAGR of 21.3% during the forecast period. The report on the AI in precision medicine market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by proliferation of large scale, multi-modal healthcare data, intensifying demand for personalized therapies and improved patient outcomes, and rapid advancements in AI technology and computational infrastructure.
Market Scope | |
---|---|
Base Year | 2025 |
End Year | 2029 |
Series Year | 2025-2029 |
Growth Momentum | Accelerate |
YOY 2025 | 18.9% |
CAGR | 21.3% |
Incremental Value | $880.7 mn |
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
Technavio's AI in precision medicine market is segmented as below:
By Application
By Technology
By End-user
By Geographical Landscape
This study identifies the ascendancy of generative AI in drug discovery and development as one of the prime reasons driving the AI in precision medicine market growth during the next few years. Also, AI-powered optimization and decentralization of clinical trials and emergence of AI-generated digital twins for personalized care will lead to sizable demand in the market.
The report on the AI in precision medicine market covers the following areas:
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading AI in precision medicine market vendors that include Aidoc, Bayer AG, Bristol Myers Squibb Co., Butterfly Network Inc., Cohere Inc., Deep Genomics Inc., Exscientia PLC, F. Hoffmann La Roche Ltd., Google LLC, Insilico Medicine, Microsoft Corp., Novartis AG, NVIDIA Corp., PathAI Inc., Recursion Pharmaceuticals Inc., Sanofi SA, and Tempus Labs Inc.. Also, the AI in precision medicine market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Exhibits: